Back to top
more

Baxter International (BAX)

(Delayed Data from NYSE)

$23.54 USD

23.54
12,327,695

+1.04 (4.62%)

Updated Aug 7, 2025 04:00 PM ET

After-Market: $23.53 -0.01 (-0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 37% (156 out of 246)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Headquartered in Deerfield, IL, Baxter International Inc. (BAX) is a global medical technology company. However, the company spun off its biopharmaceuticals segment into an independent entity – Baxalta Inc. Following the spinoff, the company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions.

Zacks Equity Research

Can PBM Unit Boost Express Scripts' (ESRX) Q2 Earnings?

by Zacks Equity Research

Strong performance by the PBM unit is likely to drive Express Scripts' (ESRX) top line in Q2. Home-delivery pharmacy care, specialty pharmacy care and drug data analysis services buoy optimism.

    Zacks Equity Research

    Can Solid Global Prospects Drive Align's (ALGN) Q2 Earnings?

    by Zacks Equity Research

    Align Technology (ALGN) poised to gain on continued strength in all geographies in Q2.

      Zacks Equity Research

      Will Edwards' (EW) Steady Overall Growth Drive Q2 Earnings?

      by Zacks Equity Research

      Edwards Lifesciences (EW) expected to gain from strength in all business segments and geographies in Q2.

        Zacks Equity Research

        Will Global Industrial Unit Boost Ecolab's (ECL) Q2 Earnings?

        by Zacks Equity Research

        Solid performance in the Global Industrial segment is likely to drive Ecolab's (ECL) Q2 results. However, the company faces pricing pressure in the Energy segment.

          Zacks Equity Research

          Can Diagnostic Revenues Drive PerkinElmer (PKI) Q2 Earnings?

          by Zacks Equity Research

          Strong performance in the Diagnostics Segment is likely to drive PerkinElmer's (PKI) Q2 results. The segment fortifies the company's market position in terms of exclusiveness of services.

            Zacks Equity Research

            What's in the Cards for Zimmer Biomet (ZBH) in Q2 Earnings?

            by Zacks Equity Research

            Focusing on the thrust areas like quality correction, supply recovery efforts and product introductions, Zimmer Biomet (ZBH) is expected to retain robust top-line numbers within its S.E.T. arm.

              Zacks Equity Research

              Can Overall Growth Drive Align Technology (ALGN) Q2 Earnings?

              by Zacks Equity Research

              Align Technology (ALGN) likely to gain from strength in Invisalign space as well as Scanner and Service business in Q2.

                Zacks Equity Research

                Merit Medical (MMSI) to Report Q2 Earnings: What's in Store?

                by Zacks Equity Research

                Merit Medical's (MMSI) acquisition-driven strategy to boost growth by expanding existing product offerings across all business segments in Q2.

                  Zacks Equity Research

                  Thermo Fisher (TMO) to Report Q2 Earnings: What's in Store?

                  by Zacks Equity Research

                  Thermo Fisher (TMO) continues with its impressive performance momentum across analytical instrument businesses witnessing escalating global demand.

                    Zacks Equity Research

                    Can Strategic Alliances Aid LabCorp's (LH) Q2 Earnings?

                    by Zacks Equity Research

                    LabCorp (LH) is expected to gain traction from a solid LabCorp Diagnostics segment in Q2, courtesy of a favorable price, mix, tuck-in acquisitions and organic volume.

                      Sreyoshi Mukherjee headshot

                      Trump's APAC Focus Puts Spotlight on These 3 MedTech Stocks

                      by Sreyoshi Mukherjee

                      Despite the trade war upheaval in Asia, some medical device companies stand strong in the APAC region.

                        Zacks Equity Research

                        AngioDynamics (ANGO) Misses Q4 Earnings & Revenue Estimates

                        by Zacks Equity Research

                        AngioDynamics (ANGO) misses Q4 earnings and revenue estimates; international sales high.

                          Zacks Equity Research

                          Can International Sales Drive Baxter's (BAX) Q2 Earnings?

                          by Zacks Equity Research

                          Baxter's (BAX) Q2 earnings likely to be aided by promising international ventures and acquisitions; cyclophosphamide competition raises concern.

                            Zacks Equity Research

                            Here's Why You Should Invest in Baxter (BAX) Stock Right Now

                            by Zacks Equity Research

                            Baxter's (BAX) raised 2018 guidance and strong international presence make it a lucrative pick.

                              Zacks Equity Research

                              HRC or BAX: Which Is the Better Value Stock Right Now?

                              by Zacks Equity Research

                              HRC vs. BAX: Which Stock Is the Better Value Option?

                                Zacks Equity Research

                                Stryker or Baxter: Which is a Better Pick for Your Portfolio?

                                by Zacks Equity Research

                                Stryker (SYK) and Baxter's (BAX) strong expected growth rates and rising share price make them close contenders in the MedTech industry.

                                  Zacks Equity Research

                                  5 Stocks Near 52-Week High: Is More Upside in the Cards?

                                  by Zacks Equity Research

                                  Here are some stocks trading near their 52-week high levels with potential to scale higher.

                                    Zacks Equity Research

                                    BSX or BAX: Which is a Better Pick for Your Portfolio Now?

                                    by Zacks Equity Research

                                    After considering various parameters and fundamentals, we help you make a choice between Boston Scientific (BSX) and Baxter (BAX).

                                      Zacks Equity Research

                                      Zacks.com highlights: Jazz Pharmaceuticals, Baxter International, Boise Cascade, Insight Enterprises and Comfort Systems USA

                                      by Zacks Equity Research

                                      Zacks.com highlights: Jazz Pharmaceuticals, Baxter International, Boise Cascade, Insight Enterprises and Comfort Systems USA

                                        Zacks Equity Research

                                        5 Stocks Near 52-Week High With More Room to Run

                                        by Zacks Equity Research

                                        Here are some stocks trading near their 52-week high levels and still with plenty of room for upside.

                                          Zacks Equity Research

                                          Baxter (BAX) Soars to a 52-Week High, Time to Cash Out?

                                          by Zacks Equity Research

                                          Baxter International Inc. is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for BAX for clues.

                                            Zacks Equity Research

                                            Cooper Companies (COO) Q2 Earnings & Revenues Beat Estimates

                                            by Zacks Equity Research

                                            Cooper (COO) witnesses strong growth across segments and geographies in fiscal Q2.

                                              Zacks Equity Research

                                              Here's Why You Should Invest in Baxter International Now

                                              by Zacks Equity Research

                                              Strategic buyouts consistently help Baxter (BAX) gain market traction. Recently, the company completes the consolidation of both RECOTHROM and PREVELEAK.

                                                Zacks Equity Research

                                                Zacks.com featured highlights include: Schweitzer-Mauduit, Insight, Baxter, Boise Cascade and Comfort Systems

                                                by Zacks Equity Research

                                                Zacks.com featured highlights include: Schweitzer-Mauduit, Insight, Baxter, Boise Cascade and Comfort Systems

                                                  Zacks Equity Research

                                                  5 Stocks Near 52-Week High With Potential to Scale Higher

                                                  by Zacks Equity Research

                                                  Here are some stocks trading near their 52-week high levels and still with plenty of room for upside.